Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, 100000, China
NCT Number: NCT03808272
To study the safety and effectiveness of the AXIOS Stent with Electrocautery Enhanced Delivery System for endoscopic trans enteric drainage of pancreatic pseudocyst and walled-off necrosis in Chinese population, to support the regulatory approval by CFDA
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Beijing, Beijing Municipality, 100000, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The HOT AXIOS Stent and Electrocautery- Enhanced Delivery System is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of a pancreatic pseudocyst or a walled-off necrosis with ≥ 70% fluid content.
Time frame: 28± 7 days post stent placement
defined as: placement of the AXIOS stent using the Electrocautery Enhanced AXIOS delivery system and removal of the AXIOS stent using a standard method: such as endoscopic snare or forceps.
Time frame: 28± 7 days post stent placement
defined as: at least a 50% decrease in pseudocyst's maximum diameter, based on radiographic analysis
Boston Scientific Corporation
Industry
A Prospective, Multi-center, Single-arm Study to Evaluate the Safety and Efficacy of AXIOS Stent and Electrocautery-enhanced Delivery System in Chinese Patients With Pancreatic Pseudocyst and Walled-off Necrosis(WON)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02845258
Cysts, Digestive System Diseases
Gothenburg, Sweden
View Trial DetailsNCT04494282
Cysts, Digestive System Diseases
View Trial DetailsNCT03147768
Adenocarcinoma, Adenoma
Houston, Texas, United States
View Trial DetailsNCT03797209
Cysts, Digestive System Diseases
Nagakute-Shi, Aichi-ken, Japan
View Trial Details